Fayez Sarofim & Co’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.62M | Buy |
233,339
+200
| +0.1% | +$5.23K | 0.01% | 114 |
|
|
2026
Q1 | $6.55M | Sell |
233,139
-3,148
| -1% | -$83.8K | 0.02% | 107 |
|
|
2025
Q4 | $5.88M | Sell |
236,287
-10,410
| -4% | -$263K | 0.01% | 113 |
|
|
2025
Q3 | $6.29M | Hold |
246,697
| – | – | 0.01% | 119 |
|
|
2025
Q2 | $5.98M | Sell |
246,697
-15,395
| -6% | -$359K | 0.01% | 123 |
|
|
2025
Q1 | $6.64M | Sell |
262,092
-6,983
| -3% | -$183K | 0.02% | 115 |
|
|
2024
Q4 | $7.14M | Sell |
269,075
-8,576
| -3% | -$233K | 0.02% | 111 |
|
|
2024
Q3 | $8.04M | Sell |
277,651
-154,480
| -36% | -$4.51M | 0.02% | 106 |
|
|
2024
Q2 | $12.1M | Sell |
432,131
-73,848
| -15% | -$2.03M | 0.03% | 92 |
|
|
2024
Q1 | $14M | Sell |
505,979
-194,741
| -28% | -$5.4M | 0.04% | 87 |
|
|
2023
Q4 | $19.3M | Sell |
700,720
-40,611
| -5% | -$1.23M | 0.06% | 80 |
|
|
2023
Q3 | $24.6M | Sell |
741,331
-20,274
| -3% | -$717K | 0.08% | 77 |
|
|
2023
Q2 | $27.9M | Sell |
761,605
-69,125
| -8% | -$2.69M | 0.1% | 75 |
|
|
2023
Q1 | $33.9M | Buy |
830,730
+18,295
| +2% | +$790K | 0.12% | 75 |
|
|
2022
Q4 | $41.6M | Sell |
812,435
-37,043
| -4% | -$1.78M | 0.15% | 71 |
|
|
2022
Q3 | $37.2M | Buy |
849,478
+39,657
| +5% | +$1.93M | 0.15% | 70 |
|
|
2022
Q2 | $42.5M | Buy |
809,821
+7,030
| +0.9% | +$358K | 0.16% | 71 |
|
|
2022
Q1 | $41.6M | Buy |
802,791
+25,334
| +3% | +$1.31M | 0.13% | 75 |
|
|
2021
Q4 | $45.9M | Buy |
777,457
+35,825
| +5% | +$1.77M | 0.14% | 76 |
|
|
2021
Q3 | $31.9M | Sell |
741,632
-8,110
| -1% | -$359K | 0.11% | 81 |
|
|
2021
Q2 | $29.4M | Buy |
749,742
+45,888
| +7% | +$1.78M | 0.1% | 81 |
|
|
2021
Q1 | $25.5M | Sell |
703,854
-21,754
| -3% | -$772K | 0.09% | 78 |
|
|
2020
Q4 | $26.7M | Sell |
725,608
-34,751
| -5% | -$1.27M | 0.1% | 75 |
|
|
2020
Q3 | $26.5M | Buy |
760,359
+10,122
| +1% | +$355K | 0.11% | 73 |
|
|
2020
Q2 | $23.3M | Buy |
750,237
+35,739
| +5% | +$1.21M | 0.11% | 74 |
|
|
2020
Q1 | $22.1M | Sell |
714,498
-2,943
| -0.4% | -$100K | 0.14% | 70 |
|
|
2019
Q4 | $26.7M | Buy |
717,441
+6,770
| +1% | +$241K | 0.13% | 74 |
|
|
2019
Q3 | $24.2M | Buy |
710,671
+2,046
| +0.3% | +$74.4K | 0.12% | 73 |
|
|
2019
Q2 | $29.1M | Sell |
708,625
-121,342
| -15% | -$4.82M | 0.15% | 69 |
|
|
2019
Q1 | $33.4M | Buy |
829,967
+125,028
| +18% | +$5.01M | 0.18% | 66 |
|
|
2018
Q4 | $29.2M | Buy |
704,939
+764
| +0.1% | +$31.7K | 0.18% | 68 |
|
|
2018
Q3 | $29.4M | Sell |
704,175
-2,862
| -0.4% | -$110K | 0.15% | 69 |
|
|
2018
Q2 | $24.3M | Sell |
707,037
-9,235
| -1% | -$316K | 0.13% | 70 |
|
|
2018
Q1 | $24.1M | Sell |
716,272
-1,293
| -0.2% | -$44.5K | 0.13% | 71 |
|
|
2017
Q4 | $24.7M | Sell |
717,565
-790
| -0.1% | -$26.9K | 0.13% | 70 |
|
|
2017
Q3 | $24.3M | Sell |
718,355
-2,065
| -0.3% | -$66.4K | 0.13% | 73 |
|
|
2017
Q2 | $23M | Sell |
720,420
-9,471
| -1% | -$299K | 0.12% | 77 |
|
|
2017
Q1 | $23.7M | Buy |
729,891
+36,209
| +5% | +$1.14M | 0.13% | 76 |
|
|
2016
Q4 | $21.4M | Buy |
693,682
+1,084
| +0.2% | +$33.1K | 0.12% | 77 |
|
|
2016
Q3 | $22.3M | Sell |
692,598
-12,327
| -2% | -$412K | 0.12% | 75 |
|
|
2016
Q2 | $23.5M | Buy |
704,925
+101,791
| +17% | +$3.25M | 0.13% | 76 |
|
|
2016
Q1 | $17M | Sell |
603,134
-2,064
| -0.3% | -$59K | 0.1% | 83 |
|
|
2015
Q4 | $18.5M | Sell |
605,198
-28,693
| -5% | -$903K | 0.11% | 81 |
|
|
2015
Q3 | $18.9M | Sell |
633,891
-16,312
| -3% | -$523K | 0.11% | 83 |
|
|
2015
Q2 | $20.7M | Buy |
650,203
+3,544
| +0.5% | +$116K | 0.11% | 76 |
|
|
2015
Q1 | $21.3M | Sell |
646,659
-984
| -0.2% | -$31.3K | 0.1% | 75 |
|
|
2014
Q4 | $19.1M | Sell |
647,643
-6,437
| -1% | -$185K | 0.09% | 75 |
|
|
2014
Q3 | $18.4M | Sell |
654,080
-4,654
| -0.7% | -$131K | 0.09% | 75 |
|
|
2014
Q2 | $18.6M | Buy |
658,734
+12,348
| +2% | +$352K | 0.08% | 75 |
|
|
2014
Q1 | $19.7M | Sell |
646,386
-2,285
| -0.4% | -$68.1K | 0.09% | 75 |
|
|
2013
Q4 | $18.9M | Buy |
+648,671
| New | +$18.9M | 0.09% | 75 |
|
|
2013
Q2 | $19.8M | Buy |
+745,916
| New | +$20.6M | 0.1% | 71 |
|
Other funds holding PFE
Fayez Sarofim & Co's PFE Position: Q2 2026 in Review
Fayez Sarofim & Co increased its Pfizer (PFE) stake by 0.09% in Q2 2026, buying an estimated $5.23K and bringing the position to 233,339 shares worth $5.62M. The position accounts for 0.01% of the portfolio, ranked #114.
Fayez Sarofim & Co first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $45.9M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Fayez Sarofim & Co held 233,339 shares of Pfizer worth $5.62M as of Q2 2026.
- Fayez Sarofim & Co bought 200 Pfizer shares in Q2 2026, an estimated $5.23K.
- Pfizer made up 0.01% of Fayez Sarofim & Co's portfolio in Q2 2026, its #114 holding.
- Fayez Sarofim & Co first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Fayez Sarofim & Co's Pfizer position peaked at $45.9M in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Fayez Sarofim & Co's 13F filing for Q2 2026, filed 17 Aug 2026.